SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 224 filers reported holding SAGE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,032,252 | -79.7% | 50,158 | -53.6% | 0.00% | -77.8% |
Q2 2023 | $5,078,630 | +4.2% | 108,010 | -7.0% | 0.01% | 0.0% |
Q1 2023 | $4,874,620 | +40.8% | 116,173 | +28.0% | 0.01% | +28.6% |
Q4 2022 | $3,461,586 | +58.0% | 90,760 | +62.2% | 0.01% | +75.0% |
Q3 2022 | $2,191,000 | -34.7% | 55,948 | -26.2% | 0.00% | +33.3% |
Q3 2021 | $3,357,000 | +54.8% | 75,768 | +98.5% | 0.00% | +50.0% |
Q2 2021 | $2,168,000 | -43.1% | 38,178 | -25.0% | 0.00% | -50.0% |
Q1 2021 | $3,810,000 | +245.4% | 50,908 | +299.6% | 0.00% | +300.0% |
Q4 2020 | $1,103,000 | -45.4% | 12,740 | -54.5% | 0.00% | -50.0% |
Q4 2019 | $2,021,000 | -88.5% | 27,995 | -77.6% | 0.00% | -88.2% |
Q3 2019 | $17,578,000 | -23.2% | 125,019 | -0.0% | 0.02% | -19.0% |
Q2 2019 | $22,892,000 | +27.9% | 125,029 | +11.1% | 0.02% | +16.7% |
Q1 2019 | $17,904,000 | +665.1% | 112,569 | +352.0% | 0.02% | +500.0% |
Q4 2018 | $2,340,000 | -56.4% | 24,904 | -34.4% | 0.00% | -40.0% |
Q3 2018 | $5,366,000 | -9.8% | 37,986 | 0.0% | 0.01% | -16.7% |
Q2 2018 | $5,946,000 | -17.0% | 37,986 | -14.6% | 0.01% | -14.3% |
Q1 2018 | $7,163,000 | +939.6% | 44,474 | +962.4% | 0.01% | +600.0% |
Q4 2017 | $689,000 | +44.4% | 4,186 | -45.3% | 0.00% | – |
Q3 2017 | $477,000 | +30.7% | 7,654 | +67.2% | 0.00% | – |
Q2 2017 | $365,000 | -33.0% | 4,578 | -40.3% | 0.00% | -100.0% |
Q1 2017 | $545,000 | -90.7% | 7,666 | -94.5% | 0.00% | -85.7% |
Q3 2015 | $5,846,000 | +47.1% | 138,145 | +153.8% | 0.01% | +75.0% |
Q2 2015 | $3,973,000 | – | 54,425 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 312,000 | $29,886,000 | 5.11% |
DAFNA Capital Management LLC | 104,306 | $9,991,000 | 4.97% |
Palo Alto Investors LP | 850,977 | $81,515,000 | 4.34% |
BB BIOTECH AG | 1,375,229 | $131,733,000 | 4.22% |
Eventide Asset Management | 936,000 | $89,659,000 | 3.97% |
TRV GP II, LLC | 37,362 | $3,579,000 | 3.56% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 146,179 | $14,002,000 | 2.11% |
SUFFOLK CAPITAL MANAGEMENT LLC | 111,908 | $10,720,000 | 2.06% |
OAK RIDGE INVESTMENTS LLC | 231,483 | $22,174,000 | 1.60% |
Rhenman & Partners Asset Management AB | 137,339 | $13,156,000 | 1.50% |